Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Referral name

Referral status

Referral type

Referral reference number

Referral decision making model

Referral authorisation model

Referral procedure start date

Medicine type

Related medicine

Therapeutic area

Last updated

First published

1 results

Sort by

List item

Referral: Janus Kinase inhibitors (JAKi)

tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Under evaluation, Last updated: 13/06/2022